Roche bags USFDA nod for Vabysmo to treat retinal vein occlusion Ruchika Sharma27 Oct 2023 11:32 AM IST"Vabysmo is a new treatment option for RVO that can help people preserve and improve their vision, with the added benefit of retinal drying," said...
Roche settles patent lawsuit against Biogen over biosimilar version of rheumatoid arthritis drug Actemra Ruchika Sharma26 Oct 2023 1:30 PM ISTBasel: Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of...
Roche acquires Telavant Holdings for USD 7.1 billion Ruchika Sharma24 Oct 2023 12:30 PM ISTBasel: Roche has announced the entry into a definitive agreement to acquire Telavant Holdings, Inc., a Roivant company, owned by Roivant Sciences Ltd....
Royalty Pharma to pay USD 1 billion for Roche SMA drug royalties Ruchika Sharma22 Oct 2023 10:00 AM ISTPTC said it plans to use the proceeds from the deal to pay back its debt from Blackstone Life Sciences and to fund planned operations.
Late-breaking data for Fenebrutinib show brain penetration, significant reduction in lesions in patients with relapsing multiple sclerosis: Roche Ruchika Sharma15 Oct 2023 9:00 AM ISTBasel: Roche has announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces...
Vabysmo maintained vision improvements with extended treatment intervals up to 4 months for people with retinal vein occlusion in phase III studies: Roche Ruchika Sharma10 Oct 2023 2:30 PM ISTBasel: Roche has announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended treatment...
Roche presents positive results for spinal muscular atrophy treatment Evrysdi in babies Ruchika Sharma8 Oct 2023 11:00 AM ISTBasel: Roche has presented positive results from the primary analysis of the ongoing RAINBOWFISH study assessing the efficacy and safety of Evrysdi...
Roche open to big acquisitions 'if it makes scientific and financial sense', CEO tells NZZ am Sonntag Ruchika Sharma11 Sept 2023 12:23 PM ISTZurich: Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker...
Phase 2 study of Zilebesiran met primary endpoint: Roche,Alnylam Ruchika Sharma9 Sept 2023 12:38 PM ISTBasel: Roche and Alnylam have announced that the Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed...
Roche Alecensa delivers unprecedented Phase III results for people with ALK positive early stage lung cancer Ruchika Sharma4 Sept 2023 1:30 PM ISTBasel: Roche has announced that the Phase III ALINA study evaluating Alecensa (alectinib), compared with platinum-based chemotherapy, met its primary...
Roche Tecentriq SC approved in Great Britain Ruchika Sharma2 Sept 2023 10:00 AM ISTInjecting Tecentriq subcutaneously (under the skin) takes approximately seven minutes.
Strides Singapore arm bags USFDA nod for Mycophenolate Mofetil for Oral Suspension Ruchika Sharma31 Aug 2023 1:30 PM ISTMycophenolate Mofetil for Oral Suspension belongs to a group of medicines called immunosuppressants.
